Phenotypeca engages Grant Writing specialist, Dr Emma Richardson, to lead non-dilutive funding strategy at the end of August

August 2020

We are delighted to announce that Dr Emma Richardson has been engaged to support us in obtaining grant funding from non-dilutive sources starting on 24th August.

Emma is a Grant Writing specialist who is highly proficient in innovation management and bid writing, having prepared over 100 funding applications for R&D firms in the Life Science, Medical Device, and Biotechnology sectors, for a range UK and EU funders. 

Grants funding is a significant source of income for Phenotypeca until the platform is ready to deliver successful commercial projects from 2021 onwards.

Emma has a 1st Class BSc in Molecular Biology and Biochemistry from Durham University, and a PhD in RNA Biology from the University of Nottingham, and has spent the past seven years working a specialist business consultant helping companies of all sizes to achieve funding to develop new products and services.